Today’s AI Top Pick: UWMC

7/23/2026 · Highly Shorted Oversold screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Highly Shorted OversoldUWMCBUY NOW8.6 / 107/23/2026

UWMC is the cleanest 'strong fundamentals + confirmed tape' setup in this pool. On the fundamentals, it's the highest-quality name that also passed the short-interest/oversold screen: PE 6.84, fwdPe 4.13, PEG 0.06, ROE 33.65%, operating margin 56.76%, gross margin 87.02%, and salesYoY +37.1% — that's not a broken company, that's a beaten-down mortgage originator (perfYtd -57.99%) with a fundamental_score of 6.0 and 20.94% short float that has been squeezed by the rate cycle rather than by fraud. The forecast tape confirms hard across every timeframe — this is the multi-TF agreement the screen is looking for. 1h fc_short/mid/long: +69.9/+84.4/+59.9%. 4h: +63.5/+109.2/+113.6%. 1d: +84.4/+121.9/+116.1%. 1wk: +46.1/+97.4/+137.2%. Kronos bullish_prob 1.0 and near_term_bullish 1.0. Crucially, we are NOT chasing: position_in_21bar_range is 40.7% (1h), 7.1% (4h), 6.7% (1d), 0% (1wk), with a weekly drawdown of -50.1% from the 21-bar high. This is a name that has been left for dead and just started to base — the opposite of an extended entry. Why TODAY vs. waiting: the daily is already curling (recent_21bar_pct only -7.43% vs. -47.9% on the weekly), which is textbook post-capitulation early-turn. The recent Morgan Stanley PT of $3 (equal-weight) is actually ~60% above the current $1.87, not a bearish call, and the Motley Fool 'dividend warning' article is the sort of sentiment nadir that typically marks these bottoms — the tape is disagreeing with the doom narrative. The main headline risk is a formal dividend cut, which is why I'm not sizing this like a low-vol name. But at $1.87 with 116% analyst upside, ROE >30%, and a forecast wall pointing up on all four timeframes with clean base position, this is the best risk/reward on the board.

Entry zone

$1.82–$1.92 (starter today; add on any dip to $1.75)

Stop loss

$1.63 (below the recent 21-bar weekly low; -13% from entry)

First target

$2.35 (fill of prior breakdown gap, ~+26%)

Longer target

$2.95–$3.20 (Morgan Stanley PT $3 / 1wk fc_long implied ~$4.44 — take partial at $3, trail rest)

Risks

Dividend cut risk — the 19%+ yield is flagged as unsustainable; a cut could re-price the stock down 15–20% on the day.
Short float 20.94% cuts both ways — squeeze potential but also elevated volatility on any bad rate print.
Debt/Equity 70.65 leaves little cushion if mortgage volumes deteriorate further.
Recom of 2.30 (Hold-leaning) and Morgan Stanley Equal-Weight mean no imminent Street upgrade catalyst.
Weekly drawdown -50% and perfYear -60% mean the trend is not yet confirmed — a break below $1.63 invalidates the base.

Honorable mentions

RUNCleanest fundamentals-plus-story combo behind UWMC — PE 5.12, ROE 19.13%, profit margin 17.94%, positive CA grid deal headline, bullish_prob 1.0, near_term_bullish 0.8, and pos_in_range 0–2% on daily/weekly (deep base). Forecasts are more modest than UWMC (+29–72% across TFs) but very consistent and headline flow is net positive.

MPRare-earth thesis is live — Trump defense critical-minerals push, Needham reiterated Buy at $73. bullish_prob 1.0, near_term_bullish 0.8, and 1h/4h/1d forecasts all +9–36%. Held back to #3 by weekly forecasts turning negative (-26 to -41%), meaning this may be a trade not an investment.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	UWMC	BUY NOW	8.6	Best fundamentals in the pool + 4/4 timeframe bullish forecasts + deep base at 0–7% of daily/weekly range.
2	RUN	BUY NOW	7.7	PE 5.12/ROE 19% at YTD lows with CA grid deal catalyst and multi-TF bullish alignment.
3	MP	BUY NOW	7.1	Rare-earth policy tailwind with 1h/4h/1d forecasts all up 9–36%; weekly forecast the only wart.
4	ASPI	BUY PULLBACK	6.6	Helium/Noble Africa catalysts real, near_term_bullish 1.0, but weekly forecasts negative and fundamentals still weak.
5	EOSE	BUY PULLBACK	6.4	Explosive 4h/1d forecasts (+133/+177% long) on defense wins, but fund_score -2 and 30% short float make it whippy.
6	PEGA	BUY PULLBACK	6.0	Best fundamentals (fund_score 7.25) but earnings miss/AI reset is a fresh landmine — wait for base to hold.
7	PCT	BUY PULLBACK	5.7	Mitsui/Japan catalyst and near_term_bullish 1.0 offset by DebtEq 99.58 and -2214% profit margin.
8	SERV	WAIT	5.5	1d forecasts +82–109% but PS 79 and cash-burn make this a lottery ticket, not an investment.
9	TOYO	WAIT	5.3	Fund_score 8.0 is elite (PE 4.63, PEG 0.03) but $50M recent offering is dilutive and expected_return_pct is negative.
10	AMPX	WAIT	5.0	Cramer/Jones Trading tailwind but 1wk forecasts turn negative and near_term_bullish only 0.2.
11	LAC	WAIT	4.7	RSI 27.27 deep oversold with +34–60% mid-term forecasts but no revenue and no near-term catalyst.
12	CRML	WAIT	4.5	Overvaluation flags and a retracted press release muddy the rare-earth story despite Trump-era tailwind.
13	FUN	WAIT	4.3	Weekly forecast +52–124% is huge but 1h at 80% of range means you're chasing today.
14	BEAM	WAIT	4.0	Cathie Wood buying + BofA Buy but bullish_prob 0 and 1d forecasts turn negative.
15	KPTI	WAIT	3.9	Phase 3 catalyst ahead but weekly and 4h forecasts negative and bullish_prob 0.
16	EVMN	WAIT	3.8	Insider buying is a plus and forecasts strong (+69–96% daily) but no weekly TF data and PS 41 is stretched.
17	LUNR	WAIT	3.7	Craig-Hallum Buy but weekly forecast -23 to -37% and dd -67% on 1wk say the trend is not turning yet.
18	INV	WAIT	3.5	Big forecasts but PS 86.6, op margin -3586% and CEO transition make it a pure speculation.
19	QUCY	WAIT	3.4	$2M order is real but $26M cap and no TFs beyond 1d/1wk make it un-investable at size.
20	TDC	WAIT	3.3	Real ROE 117.76 and platform launch story but bullish_prob 0 and 1d forecasts turn negative.
21	SOC	WAIT	3.0	Fwd PE 2.84 is intriguing but California regulatory fight is binary and expected_return null.
22	CAPR	WAIT	2.8	FDA panel next week is binary — no reason to front-run it with bullish_prob 0.6.
23	BIRD	WAIT	2.6	Rebrand momentum but $24M cap, -21% sales YoY and 1wk forecast -27 to -29% say wait.
24	NN	AVOID	2.5	PS 433, revenue -34.6% YoY, and weekly forecast -24 to -34% — screen passes but tape says no.
25	NTLA	AVOID	2.4	Wolfe downgrade to Underperform with $9 PT is a fresh negative catalyst; short float 36.87% adds to pain risk.
26	ARRY	AVOID	2.3	JP Morgan just downgraded to Neutral with $8 PT — fundamentals ok but flow is against you.
27	ADTN	AVOID	1.9	Q2 revenue guidance cut is a fresh landmine — do not buy into a guide-down.
28	SNBR	AVOID	1.7	$2.88M cap with perfYtd -98.52% — this is a delisting risk, not a screen candidate.
29	TNON	AVOID	1.6	FDA clearance positive but $0.38 offering priced twice current $0.19 = active dilution death spiral.
30	BTCT	AVOID	1.4	$7.3M cap plus a fresh private placement — dilution risk overwhelms any signal.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord